Cited by 270Retinal Diseases and TreatmentsRetinal Development and DisordersRetinal Imaging and Analysis

Unraveling a Multifactorial Late-Onset Disease: From Genetic Susceptibility to Disease Mechanisms for Age-Related Macular Degeneration

Open access
Swaroop, Anand, Chew, Emily Y., Bowes Rickman, Catherine, Abecasis, Gonçalo R.·2009·Annual Review of Genomics and Human Genetics

Abstract

Aging-associated neurodegenerative diseases significantly influence the quality of life of affected individuals. Genetic approaches, combined with genomic technology, have provided powerful insights into common late-onset diseases, such as age-related macular degeneration (AMD). Here, we discuss current findings on the genetics of AMD to highlight areas of rapid progress and new challenges. We also attempt to integrate available genetic and biochemical data with cellular pathways involved in aging to formulate an integrated model of AMD pathogenesis.

AI snapshot

Written from the paper’s full text.

TL;DR

This review synthesizes genetic, epidemiologic, pathologic, and animal-model evidence on age-related macular degeneration (AMD) and proposes a “multiple-hit” model in which genetic susceptibility, aging-related cellular decline, and environmental exposures combine to cross a disease threshold. It highlights complement pathway variants (especially CFH) and ARMS2/HTRA1 as major genetic contributors and discusses implications for prevention and anti-VEGF treatment.

Key findings

  • AMD is a leading cause of severe incurable vision impairment; advanced AMD prevalence rises from ~0.2% at ages 55–64 to 13% in those older than 85 years, and in the USA approximately 1.75 million people aged ≥40 have advanced AMD and another 7.3 million have intermediate AMD.
  • Genetic factors are substantial: twin studies suggest as much as 71% of variation in overall AMD severity is genetically determined; the strongest signals are in the complement pathway (CFH, C2/CFB, C3, CFI) and at ARMS2/HTRA1.
  • Environmental and modifiable risks include smoking, which typically confers about a two-fold increased risk of advanced AMD; AREDS high-dose antioxidant vitamins plus zinc/copper slowed progression to advanced AMD by 25%, with potential to prevent 300,000 individuals from developing advanced AMD over 5 years.
  • For neovascular AMD, intravitreal ranibizumab prevented vision loss and improved vision: mean increase of 7 letters in treated patients versus decrease of 10 letters in placebo/sham-injected controls (P < 0.001).

Methods

  • Narrative review integrating human genetics (linkage, candidate-gene association, genome-wide association), epidemiology, pathology, aging biology, and mouse models of AMD.
  • Uses the AREDS classification of AMD and cites population-based prevalence data, including MESA estimates by race/ethnicity: 2.4% African-American, 4.2% Hispanic, 4.6% Chinese-descent, and 5.4% Caucasian persons aged 45–85 years.
  • Main synthesis is an integrated “multiple-hit” model with three stages: initiation by genetic susceptibility, modification by aging-associated changes, and clinical manifestation after environmental triggers.

Limitations

  • The paper states that the multiple-hit model is “conceptually convenient” but “obviously might not reflect the full complexity of susceptibility to AMD.”
  • It cautions that many candidate-gene association findings are tentative, not as widely replicated, and that publication bias cannot be discounted without large definitive confirmatory studies.
  • It notes that no mouse model perfectly mimics AMD in genetic susceptibility, advanced age, and environmental factors, and that human aging-retina expression studies are hampered by difficulty obtaining patient material and inter-individual variability; as a review, it also does not present new primary data or a systematic meta-analysis.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1146/annurev.genom.9.081307.164350

Cites

184 of 184 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

0 of 154 cited sources checked · 0 supported · 0 flagged

  • Findingcitation

    Initial expression analyses of GFP-tagged rod photoreceptors purified from mouse retinas demonstrate aging-associated changes in genes involved in mitochondrial function, protein degradation, and apoptosis.

    “Initial expression analyses of GFP-tagged rod photoreceptors purified from the retinas of mice (5) demonstrate aging-associated changes in genes involved in mitochondrial function, protein degradation, and apoptosis (S. Parapuram & A. Swaroop, unpublished data).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites (S. Parapuram & A. Swaroop, unpublished data)

      Not checked in the free run.

  • Premisecitation

    Age is the strongest risk factor associated with the development of AMD.

    “Age is the strongest risk factor associated with the development of AMD (3, 112, 140) (Figure 3).”
    • Also stated in: § INTEGRATING THE BIOLOGY OF AGING IN STUDIES OF AMD · plain
      “Aging is the single strongest risk factor for AMD; hence it is critical to integrate the biology of aging in models of AMD.”
    Quote in the paperSubstantial claim0 of 3 sources checked
    • cites [3] source

      Not checked in the free run.

    • cites [112] source

      Not checked in the free run.

    • cites [140] source

      Not checked in the free run.

  • Premisecitation

    Epidemiological studies have revealed differences in the prevalence of advanced AMD among different ethnic groups.

    “Epidemiological studies have revealed differences in the prevalence of advanced AMD among different ethnic groups (51, 3, 141).”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [51] source

      Not checked in the free run.

    • cites [3] source

      Not checked in the free run.

    • cites [141] source

      Not checked in the free run.

  • Premisenone given

    Early pathological changes in AMD include the appearance of basal deposits in Bruch's membrane.

    “Early pathological changes in AMD include the appearance of basal deposits in Bruch’s membrane, which is made up of the basement membranes of the RPE and the choriocapillaris.”
    Quote in the paperNot a substantial claim
  • Premisecitation

    Biochemical analysis of drusen has identified glycoconjugates and components found in atherosclerotic plaques, including vitronectin, apolipoprotein B and E, alpha-crystallin, complement proteins, and lipids.

    “Biochemical analysis of drusen has identified glycoconjugates and components found in atherosclerotic plaques including vitronectin, apolipoprotein B and E, alpha-crystallin, complement proteins, and lipids (32, 106, 115).”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [32] source

      Not checked in the free run.

    • cites [106] source

      Not checked in the free run.

    • cites [115] source

      Not checked in the free run.

  • May combine two claims. 35
  • Classified as probably not a substantial claim. 14
  • May combine two claims.

    Premisecitation

    The incidence of early AMD, large drusen and pigmentary changes in intermediate AMD, and choroidal neovascularization and geographic atrophy in advanced AMD increase with advancing age.

    “The incidence of early AMD, large drusen and pigmentary changes in intermediate AMD, and choroidal neovascularization (CNV) and GA in advanced AMD increase with advancing age (51, 93).”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [51] source

      Not checked in the free run.

    • cites [93] source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Pooled data from two population-based studies estimate the prevalence of advanced AMD at about 0.2% in ages 55 to 64, increasing to 13% in those older than 85 years.

    “The pooled data from two population-based studies reveal an estimated prevalence of advanced AMD of ~0.2% in ages 55 to 64, increasing to 13% in those older than 85 years (140).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [140] source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In humans, advanced age is accompanied by increased vulnerability to disease, with progressive and generally irreversible loss of physiological functions; in the eye, these include deficits in visual processing and degenerative changes in retinal neurons and the RPE.

    “In humans, advanced age is accompanied by increased vulnerability to disease, with progressive and generally irreversible loss of physiological functions; in the eye, these include deficits in visual processing and degenerative changes in retinal neurons (particularly rods and ganglion cells) and the RPE (16, 78).”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [16] source

      Not checked in the free run.

    • cites [78] source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Additional environmental factors that may influence AMD pathogenesis include sunlight exposure, alcohol use, and infection of bacterial pathogens, particularly Chlamydia pneumoniae.

    “Additional environmental factors that may influence AMD pathogenesis include sunlight exposure (33, 35, 85), alcohol use (23, 24, 114), and infection of bacterial pathogens (particularly Chlamydia pneumoniae) (11, 76, 81).”
    Quote in the paperNot a substantial claim0 of 9 sources checked
    • cites [33] Cruickshanks KJ, 2001, Arch. Ophthalmol.

      Not checked in the free run.

    • cites [35] source

      Not checked in the free run.

    • cites [85] source

      Not checked in the free run.

    • cites [23] source

      Not checked in the free run.

    • cites [24] source

      Not checked in the free run.

    • cites [114] source

      Not checked in the free run.

    • cites [11] source

      Not checked in the free run.

    • cites [76] source

      Not checked in the free run.

    • cites [81] source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Although the RPE is the most affected cell layer in AMD, the photoreceptor layer is also severely attenuated.

    “Although RPE is the most affected cell layer, the photoreceptor layer is also severely attenuated (87).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [87] source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Smoking is a modifiable and consistently associated environmental factor, typically resulting in about two-fold increased risk of developing advanced AMD.

    “Smoking is a modifiable and consistently associated environmental factor, typically resulting in about two-fold increased risk of developing advanced AMD (3, 112, 150, 155).”
    Quote in the paperNot a substantial claim0 of 4 sources checked
    • cites [3] source

      Not checked in the free run.

    • cites [112] source

      Not checked in the free run.

    • cites [150] source

      Not checked in the free run.

    • cites [155] source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Older individuals commonly have small drusen beneath the retina and cholesterol accumulation in Bruch's membrane.

    “Older individuals commonly have small drusen beneath the retina and cholesterol accumulation in Bruch’s membrane (64, 74).”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [64] source

      Not checked in the free run.

    • cites [74] source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    A2E and mitochondrial dysfunction are reported to impair RPE phagocytosis and activate the complement system.

    “A2E (a by-product of phototransduction, present in lipofuscin) and mitochondrial dysfunction are reported to impair RPE phagocytosis and activate the complement system (156, 178).”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [156] source

      Not checked in the free run.

    • cites [178] source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Aging is a genetically regulated process defined by progressive decline of somatic cell functions with age.

    “Aging is a genetically regulated process that is defined by progressive decline of somatic cell functions with age (46, 70).”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [46] source

      Not checked in the free run.

    • cites [70] source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    The pathogenesis of Stargardt's disease is thought to result from the accumulation of A2E in the RPE.

    “The pathogenesis of Stargardt’s disease, an early onset disorder whose symptoms resemble those of AMD, is thought to result from the accumulation of A2E in the RPE (110).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [110] source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Basal linear deposits are composed primarily of membraneous material located external to the RPE basement membrane in Bruch's membrane and are believed to be more specific to AMD.

    “basal linear deposits, which are composed primarily of membraneous material located external to the RPE basement membrane in Bruch’s membrane and are believed to be more specific to AMD (126).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [126] source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    In choroidal neovascularization, vessels eventually break through the RPE, resulting in severe clinical phenotypes including neovascular AMD, hemorrhagic AMD, and disciform AMD.

    “These vessels eventually break through the RPE (60), resulting in severe clinical phenotypes including (a) neovascular AMD, where lipid-rich fluid accumulates under the RPE and/or neural retina; (b) hemorrhagic AMD, where blood breaks through the RPE into the subretinal space; and (c) disciform AMD, where fibrous tissue with NV and altered RPE proliferates and replaces neural retina.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [60] source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Another sign of aging is the accumulation of lipofuscin, an undegradable fluorescent material; in the RPE, accumulation of lipofuscin may be due in large part to incomplete digestion of shed photoreceptor discs.

    “Another sign of aging is the accumulation of lipofuscin, an undegradable fluorescent material; in the RPE, accumulation of lipofuscin may be due in large part to incomplete digestion of shed photoreceptor discs (142).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [142] source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Soft drusen are associated with more extensive damage to the retina, RPE, and choroid, and predict more severe clinical outcomes such as geographic atrophy and choroidal neovascularization.

    “Soft drusen are associated with more extensive damage to the retina, RPE, and choroid, and predict more severe clinical outcomes, such as GA and CNV (45).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [45] source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    In the Multi-ethnic Study of Atherosclerosis, the prevalence of AMD in persons aged 45 to 85 years was 2.4% in African-Americans, 4.2% in Hispanics, 4.6% in Chinese-descent individuals, and 5.4% in Caucasians.

    “An analysis of U.S. participants in the Multi-ethnic Study of Atherosclerosis (MESA) showed the prevalence of AMD in persons aged 45 to 85 years to be 2.4% in African-Americans, 4.2% in Hispanics, 4.6% in Chinese-descent individuals, and 5.4% in Caucasians (94).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [94] source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Aging-associated expression changes in genes associated with mitochondrial function, protein metabolism, and immune response have been identified in several tissues and are consistent with some proposed mechanisms for late-onset neurodegenerative diseases.

    “Aging-associated expression changes in genes associated with mitochondrial function, protein metabolism, and immune response have been identified in several tissues (173) and are consistent with some proposed mechanisms for late-onset neurodegenerative diseases (98, 113, 124, 166).”
    Quote in the paperSubstantial claim0 of 5 sources checked
    • cites [173] source

      Not checked in the free run.

    • cites [98] source

      Not checked in the free run.

    • cites [113] source

      Not checked in the free run.

    • cites [124] source

      Not checked in the free run.

    • cites [166] source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Neovascular AMD accounts for over 90% of severe central vision loss among patients with AMD.

    “Neovascular AMD accounts for over 90% of severe central vision loss among patients with AMD (116, 154, 161).”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [116] source

      Not checked in the free run.

    • cites [154] source

      Not checked in the free run.

    • cites [161] source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Choroidal neovascularization refers to the growth of new blood vessels from the choroid through Bruch's membrane and under the RPE.

    “CNV refers to the growth of new blood vessels from the choroid through Bruch’s membrane and under the RPE (125).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [125] source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Geographic atrophy shows abnormal RPE with cellular hypotrophy and hypertrophy, hypopigmentation and hyperpigmentation, loss of photoreceptors, Bruch's membrane thinning, and degeneration of the choriocapillaris.

    “GA shows abnormal RPE with cellular hypotrophy and hypertrophy, hypopigmentation and hyperpigmentation, loss of photoreceptors, Bruch’s membrane thinning, and degeneration of the choriocapillaris (59, 103).”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [59] Green WR, 1999, Mol. Vis.

      Not checked in the free run.

    • cites [103] Lutty G, 1999, Mol. Vis.

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Genetic studies suggest modification of the susceptibility effect of ARMS2 by smoking, consistent with its involvement in mitochondrial function.

    “Genetic studies also suggest modification of the susceptibility effect of ARMS2 by smoking (128), consistent with its involvement in mitochondrial function (66, 82).”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [128] source

      Not checked in the free run.

    • cites [66] source

      Not checked in the free run.

    • cites [82] source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    The ARMS2 gene sequence is detected in primates and likely encodes a mitochondrial protein.

    “The ARMS2 gene sequence is detected in primates and likely encodes a mitochondrial protein (82).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [82] source

      Not checked in the free run.

  • May combine two claims.

    Interpretationreasoning

    Linkage studies have had only limited success in identifying complex disease susceptibility genes; nonetheless, in AMD they ultimately led to the discovery of genetic variants near CFH and ARMS2/HTRA1 as the strongest genetic contributors to AMD susceptibility.

    “Overall, linkage studies have had only limited success in identifying complex disease susceptibility genes; nonetheless, in the case of AMD they ultimately led to the discovery of genetic variants near CFH and ARMS2/HTRA1 as the strongest genetic contributors to AMD susceptibility (see below).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisenone given

    Initial reports of association with the CFH gene focused on the Y402H coding variant that alters a single amino acid residue in the CFH protein.

    “Initial reports of association with the CFH gene focused on the Y402H coding variant that alters a single amino acid residue in the CFH protein.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Twin studies demonstrated that genetic factors play a substantial role in the etiology of AMD, with some estimates suggesting that as much as 71% of the variation in the overall severity of AMD is genetically determined.

    “Twin studies demonstrated that genetic factors play a substantial role in the etiology of AMD, with some estimates suggesting that as much as 71% of the variation in the overall severity of AMD is genetically determined (133).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [133] source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Several additional complement genes have now been strongly associated with AMD, including complement 2 and/or complement factor B, complement 3, and complement factor I.

    “These include complement 2 (C2) and/or complement factor B (CFB) (56), complement 3 (C3) (170), and complement factor I (CFI) (44).”
    Quote in the paperSubstantial claim0 of 3 sources checked
    • cites [56] source

      Not checked in the free run.

    • cites [170] source

      Not checked in the free run.

    • cites [44] source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Individually, APOE candidate gene studies have been relatively small and evidence for association has been modest, although together the published studies provide stronger evidence of an association between APOE and AMD.

    “Individually, these studies have been relatively small, and evidence for association has been modest, although together the published studies provide stronger evidence of an association between APOE and AMD (10, 129, 177).”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [10] source

      Not checked in the free run.

    • cites [129] source

      Not checked in the free run.

    • cites [177] source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Premisenone given

    Biological and functional studies of ARMS2 have been difficult because of the lack of a homologous gene in common model organisms such as mouse or zebra fish.

    “Biological and functional studies of ARMS2 have been difficult because of the lack of a homologous gene in common model organisms (such as mouse or zebra fish).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Two reports implicated HTRA1 as a target of AMD susceptibility, whereas recent studies support the original claim of ARMS2 as a stronger candidate.

    “Whereas two reports implicated HTRA1 as a target of AMD susceptibility (37, 167), recent studies support the original claim (122) of ARMS2 (previously LOC387715) as a stronger candidate (52, 82).”
    Quote in the paperNot a substantial claim0 of 5 sources checked
    • cites [37] source

      Not checked in the free run.

    • cites [167] source

      Not checked in the free run.

    • cites [122] source

      Not checked in the free run.

    • cites [52] source

      Not checked in the free run.

    • cites [82] source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Initial reports of association between AMD and CFH included candidate gene approach, fine mapping of candidate loci, and the first successful whole-genome association study in humans, and were immediately replicated.

    “Initial reports of association included candidate gene approach, fine mapping of candidate loci, and the first successful whole-genome association study in humans (40, 63, 65, 95) and were immediately replicated (175).”
    Quote in the paperNot a substantial claim0 of 5 sources checked
    • cites [40] source

      Not checked in the free run.

    • cites [63] source

      Not checked in the free run.

    • cites [65] source

      Not checked in the free run.

    • cites [95] source

      Not checked in the free run.

    • cites [175] source

      Not checked in the free run.

  • May combine two claims.

    Premisereasoning

    At least three potential candidate genes reside in the ARMS2/HTRA1 region of association; however, the identity of the gene that affects disease susceptibility is a subject of controversy.

    “At least three potential candidate genes reside in the region of association; however, the identity of the gene that affects disease susceptibility is subject of controversy.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    An early attempt at fine mapping the CFH region showed that more than 20 variants in and around CFH were even more strongly associated with disease than the Y402H coding variant, potentially suggesting that regulation of expression of CFH and neighboring genes, rather than alterations in the coding sequence of CFH, mediates AMD susceptibility.

    “An early attempt at fine mapping the region showed that >20 variants in and around CFH were even more strongly associated with disease than was the Y402H coding variant, potentially suggesting that regulation of the expression of CFH and neighboring genes, rather than alterations in the coding sequence of CFH, mediates AMD susceptibility (97).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [97] source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisereasoning

    Apolipoprotein E was an early target of candidate gene studies because of its presence in drusen, its key role in transport of lipids and cholesterol, and established association in Alzheimer's disease.

    “Apolipoprotein E (APOE) was an early target of candidate gene studies because of its presence in drusen, its key role in transport of lipids and cholesterol, and established association in Alzheimer’s disease.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    This ARMS2/HTRA1 finding was later confirmed in several targeted studies and in a genome-wide association study.

    “This finding was later confirmed in several targeted studies (107) and in a GWAS (37).”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [107] source

      Not checked in the free run.

    • cites [37] source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Interpretationreasoning

    It is possible that susceptibility variants within the ARMS2 gene affect the activity of the HTRA1 promoter, so that both genes ARMS2 and HTRA1 influence AMD susceptibility.

    “It is, nonetheless, possible that susceptibility variants within the ARMS2 gene affect the activity of HTRA1 promoter, which is only a few kilobases from ARMS2, so that both genes ARMS2 and HTRA1 influence AMD susceptibility.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisereasoning

    A multitude of candidate gene association studies have been carried out for AMD; their findings have not been replicated as widely or as strongly as those summarized above and should, for now, be treated as tentative.

    “A multitude of candidate gene association studies have been carried out for AMD. Their findings, however, have not been replicated as widely or as strongly as those summarized above and should, for now, be treated as tentative.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    An association between the D299G TLR4 variant and AMD was initially reported but has not been validated.

    “an association between the D299G TLR4 variant and AMD was initially reported (176) but has not been validated (36, 39).”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [176] source

      Not checked in the free run.

    • cites [36] source

      Not checked in the free run.

    • cites [39] source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    A polymorphism in the 5′-upstream region of ERCC6 has been associated with AMD susceptibility and was even suggested to exhibit epistatic interaction with CFH variants.

    “A polymorphism in the 5′-upstream region of ERCC6, a gene implicated in DNA repair caused by oxidative stress and/or aging, has been associated with AMD susceptibility and was even suggested to exhibit epistatic interaction with CFH variants (152).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [152] source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).

    Interpretationnone given

    A significant overlap in functional pathways highlighted by disparate research strategies is gradually emerging.

    “A significant overlap in functional pathways highlighted by these disparate research strategies is gradually emerging.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Homozygosity of the M280 allele in CX3CR1 showed defective cell migration and appeared to be associated with higher AMD susceptibility.

    “homozygosity of the M280 allele showed defective cell migration and appeared to be associated with higher AMD susceptibility (30).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [30] source

      Not checked in the free run.

  • May combine two claims.

    Interpretationreasoning

    Variants in genes associated with a late-onset disease such as AMD are present since birth, implying that these are not sufficient for disease causation.

    “Variants in genes associated with a late-onset disease (such as AMD) are present since birth, implying that these are not sufficient for disease causation.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    More recently, an association between AMD and Toll-like receptor 3 was reported, but this association was not replicated in other large cohorts.

    “More recently, an association between AMD and another Toll-like receptor 3 (TLR3) was reported (168), but this association was not replicated in other large cohorts (41).”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [168] source

      Not checked in the free run.

    • cites [41] source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Interpretationreasoning

    Protective genetic haplotypes can reduce their impact on disease risk.

    “Protective genetic haplo-types can reduce their impact on disease risk.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    The resulting oxidative stress and protein misfolding are followed by lipid peroxidation and formation of protein aggregates, which may cause damage to outer-segment membrane biogenesis and RPE phagocytosis.

    “The resulting oxidative stress and protein misfolding are followed by lipid peroxidation and formation of protein aggregates, which may cause damage to outer-segment membrane biogenesis and RPE phagocytosis.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Interpretationnone given

    In the multiple-hit model, each hit represents the addition of a genetic, environmental, or aging-related risk factor that increases disease susceptibility for each individual.

    “Each hit represents the addition of a genetic, environmental, or aging-related risk factor that increases disease susceptibility for each individual.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationnone given

    Aging-associated changes may initiate the disease process and/or exacerbate the impact of genetic susceptibility variants.

    “These changes may initiate the disease process and/or exacerbate the impact of genetic susceptibility variants.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: Advanced age is the primary risk factor for AMD.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Inheritance of the e4 allele of APOE is the only well-established genetic risk factor for sporadic AD.

    “Inheritance of the e4 allele of APOE is the only well-established genetic risk factor for sporadic AD (147).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [147] source

      Not checked in the free run.

46 of 46
  • The paper relies on this without support.

    Late-onset diseases generally result from the interplay between multiple genetic susceptibility factors and environmental components.

    “These late-onset diseases generally result from the interplay between multiple genetic susceptibility factors and environmental components.”
  • The paper relies on this without support.

    Advanced age is the primary risk factor for AMD.

    “Let us discuss the biological impact of advanced age, which is the primary risk factor for AMD.”
  • The paper relies on this without support.

    Protein aggregates (lipofuscin and drusen) are hallmarks of retinal aging as well as of AMD.

    “Notably, protein aggregates (lipofuscin and drusen) are hallmarks of retinal aging as well as of AMD.”
  • The paper relies on this without support.

    AMD primarily affects the macula, a specialized region identified in the retina of primates, but not in other mammals or vertebrates.

    “AMD primarily affects the macula, a specialized region identified in the retina of primates, but not in other mammals or vertebrates.”
  • The paper relies on this without support.

    Control of modifiable risk factors such as smoking, hypertension, and elevated BMI may reduce the risk of developing AMD by as much as half.

    “Control of modifiable risks factors such as smoking, hypertension, and elevated BMI may reduce the risk of developing AMD by as much as half.”
  • The paper relies on this without support.

    Persons with bilateral large drusen and pigmentary changes have a 50% risk of progressing to advanced AMD in one eye over the next 5 years.

    “For example, persons with bilateral large drusen and pigmentary changes have a 50% risk of progressing to advanced AMD in one eye over the next 5 years.”
6 of 6

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • AMD is a highly heritable progressive neurodegenerative disease that leads to loss of central vision through death of photoreceptors.

    “AMD is a highly heritable progressive neurodegenerative disease that leads to loss of central vision through death of photoreceptors1,2.”

Cites

Flagged first, then by citations

Research works printed but not linked: 12

  1. Bishop DT, 1990, Am. J. Hum. Genet., 46, 254
  2. Bok D, 1985, Investig. Ophthalmol. Vis. Sci., 26, 1659
  3. Chen LJ, 2006, Mol. Vis., 12, 1536
  4. Cruickshanks KJ, 2001, Arch. Ophthalmol., 119, 246
  5. Curcio CA, 2000, Invest Ophthalmol. Vis. Sci., 41, 2015
  6. Gao H, 1992, Investig. Ophthalmol. Vis. Sci., 33, 1
  7. Green WR, 1999, Mol. Vis., 5, 27
  8. 10.1038/nm1709 · DOI · Paper page
  9. Lutty G, 1999, Mol. Vis., 5, 35
  10. Park KH, 2009, Mol. Vis., 15, 200
  11. Winkler BS, 1999, Mol. Vis., 5, 32
  12. Yoshida S, 2002, Investig. Ophthalmol. Vis. Sci., 43, 2554

Cited by

Sorted by citations

Authors
Swaroop, A., Chew, E. Y., Bowes Rickman, C., & Abecasis, G. R.
Affiliations
  • National Institutes of Health (US)
  • Departments of Ophthalmology and Cell Biology, Duke University Medical Center, Durham, North Carolina, 27710
  • University of Michigan (US)
Venue
Annual Review of Genomics and Human Genetics
Published
2009-09-01
Volume
10
Issue
1
Pages
19-43
ISSN
  • 1527-8204 (ISSN-L)
  • 1545-293X
OpenAlex
W2122414444
Cited by
270
References
184
Citations by year
2026: 3 · 2025: 6 · 2024: 10 · 2023: 6 · 2022: 14 · 2021: 8 · 2020: 16 · 2019: 10 · 2018: 10 · 2017: 14 · 2016: 11 · 2015: 25 · 2014: 28 · 2013: 32 · 2012: 22
FWCI
5.15
Type
journal article
Language
en
Open access
Locations
  • Annual Review of Genomics and Human Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (Z99 EY999999)
  • National Eye Institute (ZIAEY000473, ZIAEY000475, R01EY016862)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinal Development and Disorders
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
Keywords
age-related macular degeneration, genetic susceptibility, late-onset disease, aging, neurodegenerative diseases, AMD pathogenesis, gene pathways, disease mechanisms, complex diseases
MeSH terms
Animals, Disease Models, Animal, Eye, Humans, Life Style, Macular Degeneration, Age of Onset, Genetic Predisposition to Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review